New president and vice-president at the ABPI

Haseeb Ahmad, Managing director, UK, Ireland & Nordics at Novartis Pharmaceuticals, and also country president of Novartis UK, has been appointed as the new president of the ABPI, responsible for overseeing the ABPI, the ABPI Board and the ABPI’s Code of Practice. Mr Ahmad said: “We are in a golden era of medicines discovery, where innovative science is converging with a data and digital revolution. These forces are coming together to treat and potentially cure diseases on a scale the likes of which we’ve not seen before. The pharmaceutical industry, Government and the NHS must work together to ensure that patients can access innovative therapies and that we deliver the kind of healthcare that all of us in the UK deserve.”
Sanofi’s UK managing director, Hugo Fry, has been appointed as vice-president of the ABPI. Mr Fry said: “The UK is currently a hotbed for medical innovation, with discoveries that have a huge impact for people and patients all across the world. In the current Brexit environment, it is more important than ever to collaborate across government, businesses and academia to ensure that the UK can maintain its position as a leader in world class research and development.”